Jubilant Life Sciences’ Q1 consolidated net tumbles 94%

24 Jul 2012 Evaluate

Jubilant Life Sciences has reported results for first quarter ended June 30, 2012.

The company has reported a loss of Rs 73.60 crore for the quarter under review as compared to net profit of Rs 53.89 crore for the same quarter in the previous year. The total income from operation of the company has increased by 19.85% at Rs 742.57 crore for Q1FY13 as compared Rs 619.56 crore for the corresponding quarter previous year.

On consolidated basis, the group’s net profit after taxes, minority interest and share of profit of associates tumbled by 93.50% to Rs 5.01 crore for the Q1FY13 as compared to Rs 77.12 crore in Q1 FY12. However, the total income rose 30.51% to Rs 1240.30 crore in the quarter under review as compared to Rs 950.32 crore in the corresponding previous quarter.

Jubilant Pharmova Share Price

1072.05 9.00 (0.85%)
23-Dec-2024 11:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1823.60
Dr. Reddys Lab 1350.00
Cipla 1490.85
Lupin 2187.05
Zydus Lifesciences 980.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.